Home > Insider Trading > Filing (0000769993-19-000518)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879682	Viveve Medical Inc.	VIVE	()	NY

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
769993	Goldman Sachs & Co. Llc	200 West Street New York NY 10282		No	No	No	No
886982	Goldman Sachs Group Inc	200 West Street New York NY 10282		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Units	Disposition	2019-09-30	68,737	$4.55	23,688	No	4	S	Indirect	See footnotes
Common Units	Disposition	2019-10-01	23,688	$5.56	0	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Footnotes

This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs & Co. LLC ("Goldman Sachs" and together with GS Group, the "Reporting Persons"). Goldman Sachs is a subsidiary of GS Group. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
The Common Units of the Issuer reported herein as indirectly purchased were beneficially owned directly by Goldman Sachs and indirectly by GS Group.
Reflects a weighted average sale price of $4.55 per Common Unit, at prices ranging from $4.33 to $4.93 per Common Unit.
Reflects a weighted average sale price of $5.56 per Common Unit, at prices ranging from $4.76 to $5.77 per Common Unit.